References
- Oliveira SM, Goncalves-Pinho M, Freitas A, et al. Trends and costs of pertussis hospitalizations in Portugal, 2000 to 2015: from 0 to 95 years old. Infect Dis (Lonodn). 2018;50:625–633.
- Katfy K, Guiso N, Diawara N, et al. Epidemiology of pertussis in Casablanca (Morocco): contribution of conventional and molecular diagnosis tools. BMC Infectious Diseases. 2017;17:348.
- Fry NK, Duncan J, Wagner K, et al. Role of PCR in the diagnosis of pertus- sis infection in infants: 5 years’ experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol. 2009;58:1023–1029.
- Frassanito A, Nenna R, Nicolai A, et al. Infants hospitalized for Bordetella pertussis infection commonly have respiratory viral coinfections. BMC Infect Dis. 2017;17:492.
- Villegas D, Echandia-Villegas C, Echandia C. Afebrile pneumonia (whoop- ing cough) syndrome in infants at Hospital Universitario del Valle, Cali, 2001–2007. Colomb Med (Cali). 2012;43:114–118.
- Pavic-Espinoza I, Bendezú-Medina S, Herrera-Alzamora A, et al. High prevalence of Bordetella pertussis in children under 5 years old hospitalized with acute respiratory infections in Lima, Peru. BMC Infect Dis. 2015;15:554.
- Aquino-Andrade A, Martinez-Leyva G, Merida-Vieyra J, et al. Real-time polymerase chain reaction-based detec- tion of Bordetella pertussis in Mexican infants and their contacts: a 3-year multicenter study. J Pediatr. 2017;188:217–223.e1.
- Huang H, Gao Z, Liu Y, et al. Epidemiological charac- teristics and risk factors of the pertussis in infants <12 months of age in tianjin, China. Biomed Environ Sci. 2017;30:545–548.
- WHO. Pertussis vaccines: WHO position paper, August 2015– Recommendations. Vaccine. 2016;34:1423–1425.
- Cherry JD, Grimprel E, Guiso N, et al. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005;24:S25–S34.